Our results suggest that CLL cells may rely more on PARP function, or increase PARP function to promote repair and survival, and in parallel upregulate pro-survival signalling, including Bcl-2 to inhibit apoptosis. The gene discussed is PARP1; the disease is B-cell chronic lymphocytic leukemia.